U.S. markets open in 6 hours 15 minutes

Eli Lilly and Company (LLY)

NYSE - NYSE Delayed Price. Currency in USD
342.10-5.91 (-1.70%)
At close: 04:03PM EST
343.10 +1.00 (+0.29%)
After hours: 07:59PM EST
  • Dividend

    LLY announced a cash dividend of 1.13 with an ex-date of Feb. 14, 2023

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close348.01
Bid0.00 x 900
Ask0.00 x 1000
Day's Range341.53 - 348.09
52 Week Range231.87 - 384.44
Avg. Volume2,830,577
Market Cap325.056B
Beta (5Y Monthly)0.38
PE Ratio (TTM)51.44
EPS (TTM)6.65
Earnings DateFeb 02, 2023
Forward Dividend & Yield4.52 (1.32%)
Ex-Dividend DateFeb 14, 2023
1y Target Est389.56
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
10% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for LLY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Eli Lilly and Company
    Analyst Report: Eli Lilly and CompanyEli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
    Fair Value
    Economic Moat
    10 days agoMorningstar
View more